Drugs / ION717
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06153966 | Jan 2024 → Feb 2027 expected | prion disease | Ionis Pharmaceuticals, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ION717 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06153966 ↗ |
| Route | Intrathecal | “ION717 will be administered by IT injection.” NCT06153966 ↗ |